Jorgensen RA - Search Results

1

The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study.

Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, Lange SM, Rossi SS, Hofmann AF, Baldus WP. Lindor KD, et al. Among authors: jorgensen ra. Hepatology. 1995 Oct;22(4 Pt 1):1158-62. doi: 10.1016/0270-9139(95)90624-x. Hepatology. 1995. PMID: 7557866 Clinical Trial.

2

Natural history of pruritus in primary biliary cirrhosis.

Talwalkar JA, Souto E, Jorgensen RA, Lindor KD. Talwalkar JA, et al. Among authors: jorgensen ra. Clin Gastroenterol Hepatol. 2003 Jul;1(4):297-302. Clin Gastroenterol Hepatol. 2003. PMID: 15017671 Clinical Trial.

3

Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid.

Talwalkar JA, Angulo P, Keach JC, Petz JL, Jorgensen RA, Lindor KD. Talwalkar JA, et al. Among authors: jorgensen ra. J Clin Gastroenterol. 2005 Feb;39(2):168-71. J Clin Gastroenterol. 2005. PMID: 15681915 Clinical Trial.

4

Alendronate improves bone mineral density in primary biliary cirrhosis: a randomized placebo-controlled trial.

Zein CO, Jorgensen RA, Clarke B, Wenger DE, Keach JC, Angulo P, Lindor KD. Zein CO, et al. Among authors: jorgensen ra. Hepatology. 2005 Oct;42(4):762-71. doi: 10.1002/hep.20866. Hepatology. 2005. PMID: 16175618 Clinical Trial.

5

Fatigue in primary biliary cirrhosis.

Abbas G, Jorgensen RA, Lindor KD. Abbas G, et al. Among authors: jorgensen ra. Nat Rev Gastroenterol Hepatol. 2010 Jun;7(6):313-9. doi: 10.1038/nrgastro.2010.62. Epub 2010 May 11. Nat Rev Gastroenterol Hepatol. 2010. PMID: 20458334 Review.

6

Varices in early histological stage primary biliary cirrhosis.

Ali AH, Sinakos E, Silveira MG, Jorgensen RA, Angulo P, Lindor KD. Ali AH, et al. Among authors: jorgensen ra. J Clin Gastroenterol. 2011 Aug;45(7):e66-71. doi: 10.1097/MCG.0b013e3181f18c4e. J Clin Gastroenterol. 2011. PMID: 20856137

7

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid.

Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ. Joshi S, et al. Hepatology. 2002 Feb;35(2):409-13. doi: 10.1053/jhep.2002.30902. Hepatology. 2002. PMID: 11826416 Clinical Trial.

8

Results of long-term ursodiol treatment for patients with primary biliary cirrhosis.

Jorgensen R, Angulo P, Dickson ER, Lindor KD. Jorgensen R, et al. Am J Gastroenterol. 2002 Oct;97(10):2647-50. doi: 10.1111/j.1572-0241.2002.06043.x. Am J Gastroenterol. 2002. PMID: 12385454 Clinical Trial.

9

Treatment with ursodeoxycholic acid is associated with weight gain in patients with primary biliary cirrhosis.

Siegel JL, Jorgensen R, Angulo P, Lindor KD. Siegel JL, et al. J Clin Gastroenterol. 2003 Aug;37(2):183-5. doi: 10.1097/00004836-200308000-00018. J Clin Gastroenterol. 2003. PMID: 12869893 Clinical Trial.

10

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.

Lindor KD, Kowdley KV, Heathcote EJ, Harrison ME, Jorgensen R, Angulo P, Lymp JF, Burgart L, Colin P. Lindor KD, et al. Hepatology. 2004 Mar;39(3):770-8. doi: 10.1002/hep.20092. Hepatology. 2004. PMID: 14999696 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters